Global Over the Counter (OTC) Drugs Market is Expected to Reach $273 Billion by 2024, Says Variant Market Research
According to the latest report published by Variant Market Research, Global Over the Counter (OTC) Drugs Market is estimated to reach $273 billion by 2024 from $125 billion in 2016; at a CAGR of 10.2% from 2016 to 2024.
Download Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/over-the-counter-otc-diet-supplementary-market/sample-request
“Over the Counter (OTC) & Diet Supplementary Market (By Type: Analgesic & Pain Relievers, Dermatological Products, Cough, Cold, And Flu Products, Vitamin Supplements, Mineral Supplements, Ophthalmic Products; By Geography: North America, Europe, Asia-Pacific, RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015 – 2024”
Browse the full Global Over the Counter (OTC) Drugs Market Research Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/over-the-counter-otc-diet-supplementary-market
Quick accessibility of OTC drugs will drive the global OTC drugs market
Growth factors of global over the counter (OTC) drugs market are easy availability of drugs, and increase in consumer awareness related to deal with minor health problems. Though, less knowledge about OTC drugs among rural consumers may hamper the industry growth. Moreover, product advancement and expansion in emerging markets would provide growth opportunities for the market players.
Global over the counter (OTC) drugs market is classified into type and geography. The type segment further incldues dermatological products, cough, analgesic & pain relievers, cold, and flu products, vitamin supplements, mineral supplements, ophthalmic products, and others. North America, Europe, Asia-Pacific and RoW are regions are included in the global over the counter (OTC) drugs market.
North America is estimated to dominated the global market in 2016
North America accounted the highest market share in 2016, driven by rise in demand of OTC drugs in this region. Asia-Pacific is expected to grow at a fastest CAGR during the forecast period 2016-2024.
Key companies covered in the global Over the Counter (OTC) drugs market are Sanofi, Vigamox, Restacis, Bayer AG, Novartis AG, Lucentis, Pfizer Inc., Alkem Laboratories Limited, GlaxoSmithKline Plc, Johnson & Johnson Inc., and Teva Pharmaceutical Industries Ltd., among others.
Scope of Over the Counter Drug & Diet Supplement Market
- Analgesics remedies
- Dermatological remedies
- Digestive remedies
- North America
- United Kingdom
- South Korea
- South America
- Middle East
About Variant Market Research
Variant Market Research offers syndicated and customized reports to fulfill clients’ objectives. We also provide customized data packs proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.
For further information, visit https://www.variantmarketresearch.com
You can connect with us on LinkedIn here @ https://www.linkedin.com/company/variant-market-research
Head – Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco,
CA 94105,United States.